XML 66 R41.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Segment Information (Tables)
12 Months Ended
Jun. 30, 2024
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
(in millions)202420232022
Pharmaceutical and Specialty Solutions$210,019 $188,814 $164,596 
Global Medical Products and Distribution12,381 12,222 13,280 
Other4,512 4,021 3,518 
Total segment revenue226,912 205,057 181,394 
Corporate (1)(85)(78)(68)
Total revenue$226,827 $204,979 $181,326 
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Revenue by Reportable Segment
The following table presents revenue for the two reportable segments and disaggregated revenue within the remaining operating segments, included in Other, and Corporate:
(in millions)202420232022
Pharmaceutical and Specialty Solutions$210,019 $188,814 $164,596 
Global Medical Products and Distribution12,381 12,222 13,280 
Nuclear and Precision Health Solutions (2)
1,369 1,197 911 
at-Home Solutions2,869 2,584 2,394 
OptiFreight® Logistics
274 240 213 
Other4,512 4,021 3,518 
Total segment revenue226,912 205,057 181,394 
Corporate (1)(85)(78)(68)
Total revenue$226,827 $204,979 $181,326 
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
(2)Increase in 2023 relates to new product launches and changes in revenue presentation from agent to principal for certain customer contracts.
Disaggregation of Revenue [Table Text Block]
(in millions)202420232022
Pharmaceutical and Specialty Solutions$210,019 $188,814 $164,596 
Global Medical Products and Distribution12,381 12,222 13,280 
Nuclear and Precision Health Solutions (2)
1,369 1,197 911 
at-Home Solutions2,869 2,584 2,394 
OptiFreight® Logistics
274 240 213 
Other4,512 4,021 3,518 
Total segment revenue226,912 205,057 181,394 
Corporate (1)(85)(78)(68)
Total revenue$226,827 $204,979 $181,326 
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
(2)Increase in 2023 relates to new product launches and changes in revenue presentation from agent to principal for certain customer contracts.
Revenue from External Customers by Geographic Areas [Table Text Block]
The following table presents revenue by geographic area:
(in millions)202420232022
United States$225,231 $203,440 $179,471 
International1,681 1,617 1,923 
Total segment revenue226,912 205,057 181,394 
Corporate (1)(85)(78)(68)
Total revenue$226,827 $204,979 $181,326 
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Segment Profit by Reportable Segment
The following table presents segment profit for the two reportable segments and the remaining operating segments, included in Other, and Corporate:
(in millions)202420232022
Pharmaceutical and Specialty Solutions$2,015 $1,881 $1,643 
Global Medical Products and Distribution92 (147)(64)
Other
423 396 390 
Total segment profit2,530 2,130 1,969 
Corporate(1,287)(1,378)(2,576)
Total operating earnings/(loss)$1,243 $752 $(607)
Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment
The following tables present depreciation and amortization and additions to property and equipment for the two reportable segments and the remaining operating segments, included in Other, and Corporate:
(in millions)202420232022
Pharmaceutical and Specialty Solutions$184 $194 $170 
Global Medical Products and Distribution205 173 176 
Other79 71 65 
Corporate242 254 281 
Total depreciation and amortization$710 $692 $692 

(in millions)202420232022
Pharmaceutical and Specialty Solutions$76 $56 $54 
Global Medical Products and Distribution136 191 135 
Other81 52 30 
Corporate218 182 168 
Total additions to property and equipment$511 $481 $387 
Assets by Reportable Segment
The following table presents total assets for the two reportable segments and the remaining operating segments, included in Other, and Corporate at June 30:
(in millions)20242023
Pharmaceutical and Specialty Solutions$29,149 $27,715 
Global Medical Products and Distribution (1)7,047 7,903 
Other2,606 2,514 
Corporate6,319 5,217 
Total assets$45,121 $43,349 
(1)GMPD reflects a $675 million reduction in goodwill due to pre-tax impairment charges recorded during fiscal 2024.
Property and Equipment, Net by Geographic Area
The following table presents property and equipment, net by geographic area:
(in millions)20242023
United States$2,106 $2,025 
International423 436 
Property and equipment, net$2,529 $2,461